Incidence of major cardiac and cerebrovascular events after initiation of bevacizumab treatment, difference between patients achieving induction or not.

Table 2: Incidence of major cardiac and cerebrovascular events after initiation of bevacizumab treatment, difference between patients achieving induction or not.

Condition	N, ≥ 3 injections	N, < 3 injections	p-value	OR	CI
TIA	70	9	0.23	0.64	0.30 - 1.33
CVA	130	28	0. 83	1.05	0.68 - 1.63
CHF	172	25	0.14	0.72	0.46 - 1.12
MI	39	9	0.65	1.19	0.53 - 2.57